v3.26.1
Financial Instruments - Additional Information (Details)
$ in Thousands
12 Months Ended
Dec. 01, 2024
CAD ($)
Mar. 31, 2026
CAD ($)
Mar. 31, 2025
CAD ($)
Mar. 31, 2026
USD ($)
May 31, 2025
CAD ($)
May 31, 2025
USD ($)
Mar. 31, 2024
CAD ($)
Oct. 27, 2022
CAD ($)
Oct. 27, 2022
USD ($)
Disclosure of detailed information about financial instruments [line items]                  
Reasonably decrease in interest rates of borrowings   1.00%              
Reasonably increase in interest rates of borrowings   1.00%              
Unused capacity on facility   $ 53,738,000 $ 62,271,000            
Contingent consideration   2,704,000 5,359,000            
Liabilities arising from financing activities   126,785,000 115,278,000       $ 121,464,000    
Contingent consideration                  
Disclosure of detailed information about financial instruments [line items]                  
Liabilities arising from financing activities     $ 5,359,000       $ 4,082,000    
XRM Vision Inc. (a)                  
Disclosure of detailed information about financial instruments [line items]                  
Contingent consideration, achieving growth above gross margin, term 12 months                
Contingent consideration, future financial performance, consecutive period 12 months                
Contingent consideration, future financial performance, period 18 months                
Contingent consideration $ 9,759,000 5,104,000              
XRM Vision Inc. (a) | Minimum                  
Disclosure of detailed information about financial instruments [line items]                  
Potential impact on results, increase (decrease) in earnings   10,500,000              
XRM Vision Inc. (a) | Maximum                  
Disclosure of detailed information about financial instruments [line items]                  
Contingent consideration 12,000,000                
Potential impact on results, increase (decrease) in earnings   0              
XRM Vision Inc. (a) | Purchase consideration | Minimum                  
Disclosure of detailed information about financial instruments [line items]                  
Contingent consideration 0                
XRM Vision Inc. (a) | Purchase consideration | Maximum                  
Disclosure of detailed information about financial instruments [line items]                  
Contingent consideration $ 10,500,000                
eVerge Intersts, Inc.                  
Disclosure of detailed information about financial instruments [line items]                  
Contingent consideration   2,534,000     $ 4,815,000        
eVerge Intersts, Inc. | Minimum                  
Disclosure of detailed information about financial instruments [line items]                  
Potential impact on results, increase (decrease) in earnings   569,000   $ 472          
eVerge Intersts, Inc. | Maximum                  
Disclosure of detailed information about financial instruments [line items]                  
Potential impact on results, increase (decrease) in earnings   $ 5,889,000   $ 4,228          
eVerge Intersts, Inc. | Purchase consideration | Maximum                  
Disclosure of detailed information about financial instruments [line items]                  
Contingent consideration         $ 6,458,000 $ 4,700      
Canadian Dollars/USD Exchange Rate                  
Disclosure of detailed information about financial instruments [line items]                  
Change in exchange rate to foreign currencies   5.00% 11.00%            
Credit Facility                  
Disclosure of detailed information about financial instruments [line items]                  
Maximum borrowing capacity   $ 140,000,000           $ 2,786,000 $ 2,000